Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)
Arrotex Pharmaceuticals Pty Ltd
rizatriptan benzoate
Tablet, orally disintegrating
Excipient Ingredients: mannitol; crospovidone; sodium stearylfumarate; ethylcellulose; colloidal anhydrous silica; silicon dioxide; hypromellose; acesulfame potassium; Flavour
Sublingual
3, 2, 6
(S4) Prescription Only Medicine
for acute treatment of migraine attacks with or without aura.
Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-03-20